Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 18/20 | 0.65 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | SHBG | P04278 | 1/20 | 0.49 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7702311 | 0.86 | CYP19A1 (0.67) | CYP19A1ALDH1A1SHBGSERPINA6 | |
| SCHEMBL3658069 | 0.85 | CYP19A1 (0.65) | CYP19A1ALDH1A1SHBGSERPINA6 | |
| SCHEMBL9130696 | 0.85 | CYP19A1 (0.65) | CYP19A1ALDH1A1SHBGSERPINA6 | |
| SCHEMBL8209838 | 0.83 | CYP19A1 (0.62) | CYP19A1 | |
| SCHEMBL3816344 | 0.82 | SERPINA6 (0.72) | CYP19A1SLC22A1ALDH1A1SHBGSERPINA6 | |
| SCHEMBL6386655 | 0.82 | AR (0.52) | CYP19A1 | |
| SCHEMBL3660113 | 0.82 | CYP19A1 (0.58) | CYP19A1 | |
| SCHEMBL4945163 | 0.81 | SHBG (0.48) | CYP19A1SLC22A1ALDH1A1SHBGSERPINA6 | |
| SCHEMBL10623707 | 0.81 | CYP19A1 (0.51) | CYP19A1 | |
| SCHEMBL11023065 | 0.80 | CYP19A1 (0.58) | CYP19A1SHBGSERPINA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040002483-A1 | Use of ester and ether derivatives of 4-hydroxy-19-norandrosterone to increase the level of the anabolic/androgenic hormone 4-hydroxy-19-nortestosterone in humans | Paternoster, Mr. Vince | 2004-01-01 | — | — | US | disclosed |
| US-20030199486-A1 | Ester and ether derivatives of 4-hydroxy-19-nortestosterone and a method for the regulation of athletic function in humans | NUTRI SPORT PHARMACAL, INC. (US) | 2003-10-23 | — | — | US | disclosed |